masoprocol has been researched along with Kidney Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Algood, C; Daurkin, I; Eruslanov, E; Gilbert, SM; Kusmartsev, S; Perrin, GQ; Rosser, CJ; Stoffs, T; Su, LM; Vieweg, J | 1 |
Kawahito, Y; Matsuyama, M; Mitsuhashi, M; Nakatani, T; Sano, H; Takemoto, Y; Tsuchida, K; Yoshimura, R | 1 |
Davis, CJ; Feddersen, RM; Gardner, KD; Smith, AY | 1 |
Ansar, S; Athar, M; Iqbal, M | 1 |
4 other study(ies) available for masoprocol and Kidney Neoplasms
Article | Year |
---|---|
Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway.
Topics: Aged; Arachidonate 15-Lipoxygenase; Carcinoma, Renal Cell; Cells, Cultured; Chemokine CCL2; CTLA-4 Antigen; Cyclooxygenase Inhibitors; Female; Forkhead Transcription Factors; Humans; Immune Tolerance; Interleukin-10; Kidney Neoplasms; Lipoxygenase Inhibitors; Macrophages; Male; Masoprocol; Middle Aged; Nitrobenzenes; Sulfonamides | 2011 |
5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Topics: Aged; Apoptosis; Arachidonate 12-Lipoxygenase; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Female; Flavonoids; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Lipoxygenase Inhibitors; Male; Masoprocol; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors | 2005 |
Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: a case report.
Topics: Adenocarcinoma, Clear Cell; Beverages; Carcinoma, Renal Cell; Desert Climate; Female; Humans; Kidney Neoplasms; Masoprocol; Middle Aged; Plants; Polycystic Kidney Diseases | 1994 |
Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Blood Urea Nitrogen; Carcinogens; Catalase; Creatinine; Diethylnitrosamine; DNA Replication; Ferric Compounds; gamma-Glutamyltransferase; Glucosephosphate Dehydrogenase; Glutathione; Glutathione Reductase; Glutathione Transferase; Hydrogen Peroxide; Kidney; Kidney Neoplasms; Lipid Peroxidation; Liver; Male; Masoprocol; Mice; Nitrilotriacetic Acid; Ornithine Decarboxylase; Oxidation-Reduction; Oxidative Stress | 1999 |